| Item Type | Name |
|
Academic Article
|
Lack of antiemetic effect of high-dose metoclopramide.
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Chemotherapy, Cancer, Regional Perfusion
|
|
Concept
|
Drug Therapy, Computer-Assisted
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
Drug Therapy
|
|
Academic Article
|
Current status of the therapy of advanced renal carcinoma.
|
|
Academic Article
|
Chronic lymphocytic leukemia in association with a second lymphoproliferative disorder: response to chemotherapy in two cases.
|
|
Academic Article
|
A pharmacist's primer on chronotherapeutics.
|
|
Academic Article
|
Reprogramming SynchroMed pumps: unanticipated inaccuracy.
|
|
Academic Article
|
More evidence for circadian rhythm effects in cancer chemotherapy: the fluoropyrimidine story.
|
|
Academic Article
|
Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment.
|
|
Academic Article
|
Chemotherapy via implanted infusion pump: new perspectives for delivery of long-term continuous treatment.
|
|
Academic Article
|
Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma.
|
|
Academic Article
|
Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression.
|
|
Academic Article
|
Advanced transitional cell bladder cancer: a treatable disease.
|
|
Academic Article
|
The rationale for non-zero-order drug delivery using automatic, computer-based drug delivery systems (chronotherapy).
|
|
Academic Article
|
High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer.
|
|
Academic Article
|
Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences.
|
|
Academic Article
|
Timing may be a critical factor in drug therapy.
|
|
Academic Article
|
Chemotherapy-induced vomiting: circadian drug timing as a source of predictable within-patient variability.
|
|
Academic Article
|
High-dose intensity systemic therapy of metastatic bladder cancer.
|
|
Academic Article
|
Circadian timing of cancer chemotherapy.
|
|
Academic Article
|
Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats.
|
|
Academic Article
|
Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
|
|
Academic Article
|
The clinical application of chronobiology to oncology.
|
|
Academic Article
|
Peripheral sensory neuropathy and cisplatin chemotherapy.
|
|
Academic Article
|
Circadian mesor of recumbent pulse--cost-effective predictor of doxorubicin-induced congestive heart failure.
|
|
Academic Article
|
Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases.
|
|
Academic Article
|
Circadian rhythms and cancer chemotherapy.
|
|
Academic Article
|
Circadian timing in cancer treatment: the biological foundation for an integrative approach.
|
|
Academic Article
|
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.
|
|
Academic Article
|
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
|
|
Academic Article
|
Screening and breast cancer.
|
|
Academic Article
|
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.
|
|
Academic Article
|
Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
|
|
Academic Article
|
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
|
|
Academic Article
|
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer.
|
|
Academic Article
|
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer.
|
|
Academic Article
|
Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.
|
|
Academic Article
|
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.
|
|
Academic Article
|
Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
|
|
Academic Article
|
The First 2?Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
|
|
Academic Article
|
Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics.
|
|
Academic Article
|
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
|
|
Academic Article
|
Advanced cancer patients in a randomized clinical trial of night-simulating eyeglasses observed to have a normal 24-h circadian rhythm during chemotherapy.
|